| Source: |
| Type: |
| Toxicity |
| 5260- | 3BP, | Systemic Delivery of Microencapsulated 3-Bromopyruvate for the Therapy of Pancreatic Cancer |
| - | in-vivo, | PC, | NA |
| 5269- | 3BP, | The anti-metabolite KAT/3BP has in vitro and in vivo anti-tumor activity in lymphoma models. |
| - | in-vitro, | HCC, | NA |
| 5264- | 3BP, | Candidate cancer drug suspected after death of three patients at an alternative medicine clinic |
| - | Review, | Var, | NA |
| 5302- | 5-HTP, | Hippocampal ischaemia from accidental 5-Hydroxytryptophan (5-HTP) overdose case report |
| - | Case Report, | Nor, | NA |
| 5294- | 5-HTP, | Eosinophilia-myalgia syndrome case-associated contaminants in commercially available 5-hydroxytryptophan |
| - | in-vivo, | Nor, | NA |
| 7397- | Amla, | Clinical evaluation of Emblica Officinalis Gatertn (Amla) in healthy human subjects: Health benefits and safety results from a randomized, double-blind, crossover placebo-controlled study |
| - | Trial, | Nor, | NA |
| 4759- | antiOx, | Chemo, | Potential Contributions of Antioxidants to Cancer Therapy: Immunomodulation and Radiosensitization |
| - | Review, | Var, | NA |
| 3382- | ART/DHA, | Repurposing Artemisinin and its Derivatives as Anticancer Drugs: A Chance or Challenge? |
| - | Review, | Var, | NA |
| 5572- | B-Gluc, | The Effects of Orally Administered Beta-Glucan on Innate Immune Responses in Humans, a Randomized Open-Label Intervention Pilot-Study |
| - | Study, | Nor, | NA |
| 932- | BBR, | The short-term effects of berberine in the liver: Narrow margins between benefits and toxicity |
| - | in-vivo, | Nor, | NA |
| 5948- | Cela, | Recent Trends in anti-tumor mechanisms and molecular targets of celastrol |
| 6177- | Cu, | Toxicity of copper oxide nanoparticles: a review study |
| - | Review, | Nor, | NA |
| 6201- | Cuc, | Cucurbitacin B and Its Derivatives: A Review of Progress in Biological Activities |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 6681- | DCA, | Dichloroacetate (DCA) in Cancer Care |
| 6676- | Deg, | Deguelin’s Anticancer Bioactivity: Challenges and Opportunities in Medicinal Chemistry |
| - | Review, | Var, | NA |
| 1442- | Deg, | Deguelin, a novel anti-tumorigenic agent targeting apoptosis, cell cycle arrest and anti-angiogenesis for cancer chemoprevention |
| - | Review, | Var, | NA |
| 4917- | DSF, | Chemo, | Cu, | Effect of Disulfiram and Copper Plus Chemotherapy vs Chemotherapy Alone on Survival in Patients With Recurrent Glioblastoma |
| - | Trial, | GBM, | NA |
| 1324- | EMD, | Is Emodin with Anticancer Effects Completely Innocent? Two Sides of the Coin |
| - | Review, | Var, | NA |
| 6823- | EMD, | Role of emodin to prevent gastrointestinal cancers: recent trends and future prospective |
| - | Review, | Var, | NA |
| 6425- | ESTr, | Assessing the Risk of Estragole Consumption From Natural Products in the Malaysian Market by Using the Margin of Exposure Approach |
| - | Review, | Nor, | NA |
| 6848- | EVO, | Evodiamine: A Extremely Potential Drug Development Candidate of Alkaloids from Evodia rutaecarpa |
| - | Review, | Nor, | NA |
| 6955- | FA, | Women Taking a Folic Acid Supplement in Countries with Mandatory Food Fortification Programs May Be Exceeding the Upper Tolerable Limit of Folic Acid: A Systematic Review |
| - | Review, | Nor, | NA |
| 6850- | FBZ, | Drug-Induced Liver Injury in a Patient with Nonsmall Cell Lung Cancer after the Self-Administration of Fenbendazole Based on Social Media Information |
| - | Case Report, | Lung, | NA |
| 6851- | FBZ, | Severe Drug-Induced Liver Injury Due to Self-administration of the Veterinary Anthelmintic Medication, Fenbendazole |
| - | Case Report, | Var, | NA |
| 6852- | FBZ, | Differentiating fenbendazole-induced liver injury from immunotherapy hepatitis - the importance of structured causality assessment: A case report |
| - | Case Report, | Colon, | NA |
| 6860- | FBZ, | IVM, | Drug-Induced Liver Injury Following Co-ingestion of Veterinary Fenbendazole and Ivermectin for Prostate Cancer: A Case Report |
| - | Case Report, | Pca, | NA |
| 2861- | FIS, | The neuroprotective effects of fisetin, a natural flavonoid in neurodegenerative diseases: Focus on the role of oxidative stress |
| - | Review, | Nor, | NA | - | Review, | Stroke, | NA | - | Review, | Park, | NA |
| 4016- | FulvicA, | Shilajit: A Natural Phytocomplex with Potential Procognitive Activity |
| - | Review, | AD, | NA |
| 7055- | GamB, | Studies on the toxicity of gambogic acid in rats |
| - | in-vivo, | Nor, | NA |
| 7204- | GAs, | The Pharmacology and Toxicology of Ginkgolic Acids: Secondary Metabolites from Ginkgo biloba |
| - | Review, | Nor, | NA |
| 7227- | GAs, | Review of Ginkgo biloba-induced toxicity, from experimental studies to human case reports |
| - | Review, | Nor, | NA |
| 7101- | Geld, | Reactive oxygen species mediate hepatotoxicity induced by the Hsp90 inhibitor geldanamycin and its analogs |
| - | in-vitro, | Nor, | NA |
| 7098- | Geld, | Geldanamycins: Potent Hsp90 Inhibitors with Significant Potential in Cancer Therapy |
| - | Review, | Var, | NA |
| 7097- | Geld, | Geldanamycin, a Naturally Occurring Inhibitor of Hsp90 and a Lead Compound for Medicinal Chemistry |
| - | Review, | Var, | NA |
| 7108- | GEN, | Genistein: A Review on its Anti-Inflammatory Properties |
| - | Review, | Nor, | NA |
| 7113- | GEO2, | Nephrotoxicity and neurotoxicity in humans from organogermanium compounds and germanium dioxide |
| - | Review, | Nor, | NA |
| 7116- | GEO2, | Analytical product study of germanium-containing medicine by different ICP-MS applications |
| - | Study, | Nor, | NA |
| 7120- | GEO2, | Germanium dioxide-induced nephropathy: a new type of renal disease |
| - | Human, | Var, | NA |
| 7121- | GEO2, | Subacute nephrotoxicity of germanium dioxide in the experimental animal |
| - | in-vivo, | Nor, | NA |
| 7122- | GEO2, | Nephrotoxicity of germanium compounds: report of a case and review of the literature |
| - | Case Report, | Var, | NA |
| 7250- | Gink, | Ginkgetin from Ginkgo biloba: mechanistic insights into anticancer efficacy |
| - | Review, | Var, | NA |
| 7311- | Gos, | Systematic Review of Gossypol/AT-101 in Cancer Clinical Trials |
| - | Review, | CLL, | NA |
| 2079- | HNK, | Honokiol Microemulsion Causes Stage-Dependent Toxicity Via Dual Roles in Oxidation-Reduction and Apoptosis through FoxO Signaling Pathway |
| - | in-vitro, | Nor, | PC12 |
| - | in-vitro, | Nor, | MCF10 | - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | MDA-MB-468 | - | in-vitro, | PC, | Bxpc-3 |
| 6541- | MeSal, | Toxicology Answer: Oil of Wintergreen |
| - | Review, | Nor, | NA |
| 1665- | PBG, | Evidence on the Health Benefits of Supplemental Propolis |
| - | Review, | Nor, | NA |
| 1941- | PL, | Piperlongumine selectively kills cancer cells and increases cisplatin antitumor activity in head and neck cancer |
| - | in-vitro, | HNSCC, | NA |
| 4486- | Se, | Chit, | Selenium-Modified Chitosan Induces HepG2 Cell Apoptosis and Differential Protein Analysis |
| - | in-vitro, | Liver, | HepG2 |
| 1706- | SSE, | Selenium in Prostate Cancer: Prevention, Progression, and Treatment |
| - | Review, | Pca, | NA |
| 6768- | T4O, | Melaleuca alternifolia (Tea Tree) Oil: a Review of Antimicrobial and Other Medicinal Properties |
| - | Review, | Nor, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1025 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid